首页> 外文OA文献 >Exploring natural product chemistry and biology with multicomponent reactions. 5. Discovery of a novel tubulin-targeting scaffold derived from the rigidin family of marine alkaloids
【2h】

Exploring natural product chemistry and biology with multicomponent reactions. 5. Discovery of a novel tubulin-targeting scaffold derived from the rigidin family of marine alkaloids

机译:通过多组分反应探索天然产物的化学和生物学。 5.发现一种新的靶向微管蛋白的支架,该支架源自海洋生物碱的僵硬蛋白家族

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We developed synthetic chemistry to access the marine alkaloid rigidins and over 40 synthetic analogues based on the 7-deazaxanthine, 7-deazaadenine, 7-deazapurine, and 7-deazahypoxanthine skeletons. Analogues based on the 7-deazahypoxanthine skeleton exhibited nanomolar potencies against cell lines representing cancers with dismal prognoses, tumor metastases, and multidrug resistant cells. Studies aimed at elucidating the mode(s) of action of the 7-deazahypoxanthines in cancer cells revealed that they inhibited in vitro tubulin polymerization and disorganized microtubules in live HeLa cells. Experiments evaluating the effects of the 7-deazahypoxanthines on the binding of [3H]colchicine to tubulin identified the colchicine site on tubulin as the most likely target for these compounds in cancer cells. Because many microtubule-targeting compounds are successfully used to fight cancer in the clinic, we believe the new chemical class of antitubulin agents represented by the 7-deazahypoxanthine rigidin analogues have significant potential as new anticancer agents. © 2013 American Chemical Society.
机译:我们开发了合成化学,以利用7-脱氮杂嘌呤,7-脱氮杂嘌呤,7-脱氮嘌呤和7-脱氮杂泛黄嘌呤骨架来获取海洋生物碱刚性蛋白和40多种合成类似物。基于7-脱氮杂po杂黄嘌呤骨架的类似物显示出纳摩尔效价,可对抗代表预后不良,肿瘤转移和多药耐药细胞的癌症的细胞系。旨在阐明7-脱氮杂黄嘌呤在癌细胞中的作用方式的研究表明,它们抑制活体外HeLa细胞中的体外微管蛋白聚合和微管混乱。评估7-脱氮杂黄嘌呤对[3H]秋水仙碱与微管蛋白结合的影响的实验确定了微管蛋白上的秋水仙碱位点是癌细胞中这些化合物最可能的靶标。由于许多靶向微管的化合物已在临床上成功用于抗癌,因此我们相信以7-脱氮杂黄嘌呤刚性蛋白类似物为代表的新型化学类抗微管蛋白具有作为新型抗癌剂的巨大潜力。 ©2013美国化学学会。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号